News

Alliance Pharma has successfully raised £7.5m by way of a vendor share placing to part finance the initial cash element of the consideration for the acquisition. 28,846,154 new

Hadassah’s Helsinki Committee has approved the commencement of clinical trials with BrainStorm on condition of approval by the National Helsinki Committee of Israel’s Ministry of Health. The agreement

CM-AT is based on Dr Fallon’s research that showed enzyme deficiencies in autistic children, resulting in an inability to digest protein. The inability to digest protein affects the

Haemonetics’ Cymbal is a small, portable, battery operated instrument that automates blood collection from volunteer donors, improving process control and helping alleviate blood shortages. The expanded nomogram is

FDCA has made a plea to the state health ministry to allocate funds to include a software to the current system for the purpose. The agency is in

Once-daily Gilenia (0.5mg) has the potential to become the first approved oral therapy for the treatment of multiple sclerosis (MS). As a result of this designation, the standard

The company claims that Coenzyme-A is energy pure and simple. Besides its indispensable energy work, Coenzyme-A initiates the synthesis of a variety of other essential substances. These include

Mr Davis was the chief executive officer for Neurogen Corporation, which was recently acquired by Ligand Pharmaceuticals. His appointment brings the number of AP Pharma board members to

Designed for both demanding research applications and routine laboratory analysis, the Lumina delivers 0.5nm spectral bandwidth, high sensitivity and fast scanning speed, providing performance for assay development, quantification